Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys
dc.contributor.author | Rice, Kenner C. | en_US |
dc.contributor.author | Seggel, M. R. | en_US |
dc.contributor.author | Woods, James H. | en_US |
dc.contributor.author | France, Charles P. | en_US |
dc.contributor.author | Winger, Gail D. | en_US |
dc.date.accessioned | 2006-09-11T17:39:40Z | |
dc.date.available | 2006-09-11T17:39:40Z | |
dc.date.issued | 1992-11 | en_US |
dc.identifier.citation | France, C. P.; Winger, G.; Seggel, M. R.; Rice, K. C.; Woods, J. H.; (1992). "Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys." Psychopharmacology 109(3): 291-298. <http://hdl.handle.net/2027.42/46340> | en_US |
dc.identifier.issn | 0033-3158 | en_US |
dc.identifier.issn | 1432-2072 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/46340 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1365629&dopt=citation | en_US |
dc.description.abstract | The recent synthesis of fentanyl derivatives, some of which appear to have novel profiles of pharmacological effects, has provided compelling evidence that μ opioid efficacy might be altered systematically by modifications in the parent compound fentanyl. In the present study a new 4-(heteroanilido)-piperidine, compound 28, was studied for its effects in rhesus monkeys. In self-administration studies compound 28 maintained rates of lever pressing similar to those maintained by alfentanil; the reinforcing effects of compound 28 were attenuated by the opioid antagonist quadazocine. In drug discrimination studies compound 28 did not substitute for the κ agonist ethylketocyclazocine and did substitute for the μ agonist alfentanil. In morphine-treated subjects discriminating between saline and naltrexone, compound 28 did not substitute for naltrexone; however, in morphine-abstinent subjects compound 28 reversed naltrexone lever responding. Moreover, this discriminative stimulus effect in morphine-abstinent subjects was antagonized by naltrexone and by quadazocine in a manner consistent with μ receptor mediation. Compound 28 also was an effective analgesic in a warm-water, tail-withdrawal procedure and it decreased markedly respiratory function. The analgesic effects as well as the respiratory depressant effects of compound 28 were antagonized by quadazocine. Together, these results show compound 28 to be a potent, efficacious μ agonist of similar potency to alfentanil. Large differences in apparent efficacy at μ receptors between compound 28 and another compound in this series (mirfentanil), clearly demonstrate that, within this chemical family, small chemical changes can confer significant differences in pharmacologic effect. | en_US |
dc.format.extent | 1166302 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag | en_US |
dc.subject.other | Biomedicine | en_US |
dc.subject.other | Self Administration | en_US |
dc.subject.other | Drug Discrimination | en_US |
dc.subject.other | Competitive Antagonism | en_US |
dc.subject.other | Fentanyl | en_US |
dc.subject.other | Psychiatry | en_US |
dc.subject.other | Respiratory Function | en_US |
dc.subject.other | Pharmacology/Toxicology | en_US |
dc.subject.other | Opioid | en_US |
dc.subject.other | Analgesia | en_US |
dc.subject.other | Rhesus Monkey | en_US |
dc.title | Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA; Department of Psychology, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Pharmacology and Experimental Therapeutics, Louisiana State University, Medical Center, 1100 Florida Avenue, 70119, New Orleans, LA, USA | en_US |
dc.contributor.affiliationother | Laboratory of Medicinal Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA | en_US |
dc.contributor.affiliationother | Laboratory of Medicinal Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 1365629 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/46340/1/213_2005_Article_BF02245876.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF02245876 | en_US |
dc.identifier.source | Psychopharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.